ArticleCancer research2025

Therapeutic Targeting and Structural Characterization of a Sotorasib-Modified KRAS G12C-MHC I Complex Demonstrate the Antitumor Efficacy of Hapten-Based Strategies.

Apurva Pandey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.